Clinical Trial Update: Study Comparing Venlafaxine vs. Paroxetine in Panic Disorder [Phase 3]

View source ↗

Summary

Phase 3 randomized trial comparing venlafaxine with paroxetine for panic disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Panic Disorder

Drugs mentioned

• Effexor XR (venlafaxine)
• PAXIL (paroxetine hydrochloride)

Snippet

Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer | Conditions: Panic Disorders | Phase 3 | Status: COMPLETED